# Edwards Lifesciences vs IDEXX Laboratories: stocks compared

URL: https://funkfolio.com/compare/ew-vs-idxx

> Edwards Lifesciences ($60.6B, P/E 62.4) and IDEXX Laboratories ($54.4B, P/E 47.2) compared: size, valuation, margins, debt, cash and price change.

---

## Edwards Lifesciences vs IDEXX Laboratories

Edwards Lifesciences (EW), health care, and IDEXX Laboratories (IDXX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Edwards Lifesciences is worth $60.6B on the stock market and IDEXX Laboratories $54.4B: Edwards Lifesciences is valued at 11% more. Edwards Lifesciences trades at 62.4 times earnings and IDEXX Laboratories at 47.2; operating margins in their latest fiscal years were 20.8% and 31.6%. Over the past year Edwards Lifesciences's share price has moved +27.5% and IDEXX Laboratories's +4.54%.

### Key facts

- **Edwards Lifesciences market value:** $60.6B
- **IDEXX Laboratories market value:** $54.4B
- **Edwards Lifesciences P/E:** 62.4
- **IDEXX Laboratories P/E:** 47.2
- **Edwards Lifesciences revenue:** $6.1B FY to 2025-12-31
- **IDEXX Laboratories revenue:** $4.3B FY to 2025-12-31
- **Superinvestors holding both:** 4

Market values as of 18 Nov 2026, 04:30 UTC.

Edwards Lifesciences vs IDEXX Laboratories: every measure side by side

| Measure | Edwards Lifesciences | IDEXX Laboratories |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $60.6B higher | $54.4B lower |
| Revenue | $6.1B higher | $4.3B lower |
| Earnings | $1.1B higher | $1.1B lower |
| Employees | 16,000 higher | 11,000 lower |
| Total assets | $13.7B higher | $3.4B lower |
| Valuation |  |  |
| P/E | 62.4 higher | 47.2 lower |
| P/S | 10.0 lower | 12.6 higher |
| P/B | 5.6 lower | 29.1 higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability |  |  |
| Operating margin | 20.8% lower | 31.6% higher |
| Balance sheet |  |  |
| Net assets | $10.3B higher | $1.6B lower |
| Total liabilities | $3.4B higher | $1.7B lower |
| Total debt | $598.3M higher | $450M lower |
| Cash on hand | $2.9B higher | $180.1M lower |
| Price change |  |  |
| Today | -1.57% lower | -1.49% higher |
| 1 year | +27.5% higher | +4.54% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Edwards Lifesciences 124.4, IDEXX Laboratories 103.2.

- Edwards Lifesciences (EW)
- IDEXX Laboratories (IDXX)

Edwards Lifesciences and IDEXX Laboratories share prices over one year, rebased to 100: Edwards Lifesciences ends at 124.4, IDEXX Laboratories at 103.2.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | EW | IDXX |
| --- | --- | --- |
| Nov 28, 2025 | 102.3 | 112.5 |
| Dec 31, 2025 | 100.6 | 101.1 |
| Jan 30, 2026 | 96.0 | 100.2 |
| Feb 27, 2026 | 102.0 | 98.2 |
| Mar 31, 2026 | 94.5 | 84.0 |
| Apr 30, 2026 | 98.5 | 83.8 |
| May 29, 2026 | 102.0 | 84.2 |
| Jun 30, 2026 | 106.8 | 78.7 |
| Jul 31, 2026 | 101.6 | 83.6 |
| Aug 31, 2026 | 107.1 | 83.2 |
| Sep 30, 2026 | 101.9 | 78.1 |
| Oct 30, 2026 | 108.6 | 82.4 |
| Nov 17, 2026 | 124.4 | 103.2 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (4)

- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7% / 0.2%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2% / 0.2%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1% / 0.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.1% / 1.6%

#### Edwards Lifesciences only (5)

- [David Rolfe](https://funkfolio.com/gurus/david-rolfe) 3.1%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 1.6%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.2%

#### IDEXX Laboratories only (6)

- [Terry Smith](https://funkfolio.com/gurus/terry-smith) 2.9%
- [Polen Capital team](https://funkfolio.com/gurus/polen-capital) 2.2%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) 1.8%
- [Wallace Weitz](https://funkfolio.com/gurus/wallace-weitz) 1.3%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Edwards Lifesciences / IDEXX Laboratories). [Who owns EW](https://funkfolio.com/stock/EW/superinvestors) · [Who owns IDXX](https://funkfolio.com/stock/IDXX/superinvestors)

### More on Edwards Lifesciences

- [Edwards Lifesciences (EW) stock page](https://funkfolio.com/stock/EW)
- [Edwards Lifesciences market cap](https://funkfolio.com/stock/EW/market-cap)
- [Edwards Lifesciences revenue](https://funkfolio.com/stock/EW/revenue)
- [Edwards Lifesciences P/E ratio](https://funkfolio.com/stock/EW/pe-ratio)
- [Edwards Lifesciences operating margin](https://funkfolio.com/stock/EW/operating-margin)
- [Edwards Lifesciences total debt](https://funkfolio.com/stock/EW/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on IDEXX Laboratories

- [IDEXX Laboratories (IDXX) stock page](https://funkfolio.com/stock/IDXX)
- [IDEXX Laboratories market cap](https://funkfolio.com/stock/IDXX/market-cap)
- [IDEXX Laboratories revenue](https://funkfolio.com/stock/IDXX/revenue)
- [IDEXX Laboratories P/E ratio](https://funkfolio.com/stock/IDXX/pe-ratio)
- [IDEXX Laboratories operating margin](https://funkfolio.com/stock/IDXX/operating-margin)
- [IDEXX Laboratories total debt](https://funkfolio.com/stock/IDXX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Edwards Lifesciences against its closest peers

- [Edwards Lifesciences vs argenx](https://funkfolio.com/compare/argx-vs-ew)
- [Edwards Lifesciences vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-ew)
- [Edwards Lifesciences vs Cardinal Health](https://funkfolio.com/compare/cah-vs-ew)
- [Edwards Lifesciences vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-ew)

#### IDEXX Laboratories against its closest peers

- [IDEXX Laboratories vs Medline](https://funkfolio.com/compare/idxx-vs-mdln)
- [IDEXX Laboratories vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-idxx)
- [IDEXX Laboratories vs argenx](https://funkfolio.com/compare/argx-vs-idxx)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Edwards Lifesciences or IDEXX Laboratories?**

By market value, Edwards Lifesciences is the larger: $60.6B against $54.4B for IDEXX Laboratories. By revenue in its latest fiscal year, Edwards Lifesciences is the larger: $6.1B against $4.3B for IDEXX Laboratories.

**Which has the higher P/E ratio?**

Edwards Lifesciences: 62.4, against 47.2 for IDEXX Laboratories. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

IDEXX Laboratories: 31.6%, against 20.8% for Edwards Lifesciences. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Edwards Lifesciences: $598.3M, against $450M for IDEXX Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Edwards Lifesciences and IDEXX Laboratories?**

In their latest 13F filings, Brandon Haley, Steve Cohen, Baillie Gifford team and Ron Baron hold both.

### Cite this page

Funkfolio, “Edwards Lifesciences vs IDEXX Laboratories”, data as of 18 November 2026. https://funkfolio.com/compare/ew-vs-idxx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
